Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma

Stopped Axsome has conducted a review of the ongoing IST program and are unable to continue supporting this study

Conditions

• Glioma
• Glioblastoma

Interventions

• DRUG: Soliramfetol

Sponsor

Wake Forest University Health Sciences

Collaborators

• [object Object]